Business Brief -- Roberts Pharmaceutical Corp.:
   Agreement Is Signed to Sell
   29% Stake to Japanese Firm
Robert A. Vukovich, Roberts chairman and chief executive
officer, agreed to support a future Yamanouchi acquisition
bid if it's considered fair to shareholders.